PROCEPT BioRobotics Corporation Increase (Decrease) in Contract with Customer, Liability
PROCEPT BioRobotics Corporation (PRCT) reported Increase (Decrease) in Contract with Customer, Liability of $984.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-05
- PROCEPT BioRobotics Corporation increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was $356.00K.
- PROCEPT BioRobotics Corporation increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was $628.00K, a 167.23% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $1.95M, a 37.51% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $1.13M, a 21.43% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in contract with customer, liability for fiscal 2025 was $3.31M, a 11.03% decline from fiscal 2024.
- PROCEPT BioRobotics Corporation increase (decrease) in contract with customer, liability for fiscal 2024 was $3.72M, a 12.03% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation increase (decrease) in contract with customer, liability for fiscal 2023 was $3.32M, a 81.26% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation increase (decrease) in contract with customer, liability for fiscal 2022 was $1.83M, a 131.06% increase from fiscal 2021.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $984.00K 10-Q · filed 2026-08-05 | $2.94M derived: sum of 3 quarters · filed 2026-08-05 | $4.07M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $628.00K 10-Q · filed 2026-04-30 | $2.58M derived: sum of 2 quarters · filed 2026-04-30 | $3.71M derived: sum of 3 quarters · filed 2026-04-30 | $3.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.08M derived: sum of 2 quarters · filed 2026-02-26 | $3.07M derived: sum of 3 quarters · filed 2026-08-05 | $3.31M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.12M derived: sum of 2 quarters · filed 2026-08-05 | $1.35M 10-Q · filed 2025-11-05 | $2.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $223.00K 10-Q · filed 2026-08-05 | $1.64M derived: sum of 3 quarters · filed 2026-08-05 | $3.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $235.00K 10-Q · filed 2026-04-30 | $1.66M derived: sum of 2 quarters · filed 2026-04-30 | $3.09M derived: sum of 3 quarters · filed 2026-04-30 | $3.75M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.86M derived: sum of 2 quarters · filed 2026-02-26 | $3.51M derived: sum of 3 quarters · filed 2026-02-26 | $3.72M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.09M derived: sum of 2 quarters · filed 2025-11-05 | $2.29M 10-Q · filed 2025-11-05 | $2.94M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $653.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $858.00K 10-Q · filed 2025-08-07 | $1.51M derived: sum of 3 quarters · filed 2026-02-26 | $1.96M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $205.00K 10-Q · filed 2025-05-02 | $854.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.30M derived: sum of 3 quarters · filed 2026-02-26 | $2.43M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $649.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.10M derived: sum of 2 quarters · filed 2026-02-26 | $2.23M derived: sum of 3 quarters · filed 2026-02-26 | $3.32M 10-K · filed 2026-02-26 |
| 2023-09-30 | $449.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | $1.58M derived: sum of 2 quarters · filed 2024-10-28 | $2.67M 10-Q · filed 2024-10-28 | $3.18M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $2.22M 10-Q · filed 2024-08-02 | $2.73M derived: sum of 3 quarters · filed 2025-02-27 | $3.21M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.09M 10-Q · filed 2024-05-02 | $1.60M derived: sum of 2 quarters · filed 2025-02-27 | $2.08M derived: sum of 3 quarters · filed 2025-02-27 | $2.58M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $512.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $992.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.49M derived: sum of 3 quarters · filed 2025-02-27 | $1.83M 10-K · filed 2025-02-27 |
| 2022-09-30 | $480.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $975.00K derived: sum of 2 quarters · filed 2023-11-02 | $1.32M 10-Q · filed 2023-11-02 | $1.50M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $495.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $838.00K 10-Q · filed 2023-07-28 | $1.01M derived: sum of 3 quarters · filed 2024-02-28 | $1.20M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $343.00K 10-Q · filed 2023-05-04 | $520.00K derived: sum of 2 quarters · filed 2024-02-28 | $704.00K derived: sum of 3 quarters · filed 2024-02-28 | $962.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $361.00K derived: sum of 2 quarters · filed 2024-02-28 | $619.00K derived: sum of 3 quarters · filed 2024-02-28 | $792.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $184.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $442.00K derived: sum of 2 quarters · filed 2022-11-04 | $615.00K 10-Q · filed 2022-11-04 | $560.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $258.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $431.00K 10-Q · filed 2022-08-05 | $376.00K derived: sum of 3 quarters · filed 2022-08-05 | |
| 2021-03-31 | $173.00K 10-Q · filed 2022-05-06 | $118.00K derived: sum of 2 quarters · filed 2022-05-06 | ||
| 2020-12-31 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $127.00K 10-K · filed 2022-03-22 | ||
| 2020-09-30 | $182.00K 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |